A randomized, placebo-controlled study on the effects of a nutraceutical combination of red yeast rice, Silybum marianum and octasonol on lipid profile, endothelial and inflammatory parameters

Giuseppe Derosa, A. Bonaventura, L. Bianchi, D. Romano, A. D'Angelo, E. Fogari, P. Maffioli

Research output: Contribution to journalArticlepeer-review

Abstract

The aim of this study was to evaluate the effects of a combination of red yeast rice, Silybum marianum and octasonol compared to placebo on lipid profile, endothelial, and inflammatory parameters in low risk dislipidemic patients. One hundred and thirty-four dislipidemic patients were randomised to take placebo or a patented nutraceutical association in tablet form (Zeta Colest®), 1 tablet /day (immediately after the dinner), for three months in a double-blind, placebo-controlled trial. At baseline and after 3 months the following were evaluated: body weight, body mass index (BMI), fasting plasma glucose (FPG), lipid profile, soluble intercellular adhesion molecule-1 (sICAM-1), soluble vascular cell adhesion molecule-1 (sVCAM-1), soluble E-selectin (sE-selectin), metalloprotineases-2 and -9 (MMP-2 and MMP-9), high sensitivity C-reactive protein (Hs-CRP), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α). The nutraceutical combination decreased total cholesterol and low density lipoprotein cholesterol compared to baseline (p = 0.042, and p = 0.041, respectively) and to placebo (p = 0.039, and p = 0.037, respectively). Triglycerides were reduced by the active treatment (p = 0.039), but not by placebo, even if, in group to group comparison, no differences were recorded (p = 0.061). All adipocytokines were reduced by the nutraceutical combination, in particular p = 0.044 for sICAM-1, p = 0.045 for sVCAM-1, p = 0.040 for sE-selectin, p = 0.035 for MMP-2, p = 0.039 for MMP-9, p = 0.038 for Hs-CRP, p = 0.036 for TNF-α, and p = 0.036 for IL-6 compared to baseline, and p = 0.042 for sICAM-1, p = 0.043 for sVCAM-1, p = 0.042 for sE-selectin, p = 0.031 for MMP-2, p = 0.038 for MMP-9, p = 0.038 for Hs-CRP, and p = 0.043 for TNF-α, respectively, compared to placebo. We can conclude that a combination of red yeast rice, Silybum marianum and octasonol was effective in improving lipid profile, endothelial, and inflammatory parameters in low risk dislipidemic patients.

Original languageEnglish
Pages (from-to)317-324
Number of pages8
JournalJournal of Biological Regulators and Homeostatic Agents
Volume28
Issue number2
Publication statusPublished - 2014

Keywords

  • Inflammation
  • Lipid profile
  • Octasonol
  • Red yeast rice
  • Silybum marianum

ASJC Scopus subject areas

  • Physiology
  • Endocrinology
  • Cancer Research
  • Immunology
  • Physiology (medical)
  • Endocrinology, Diabetes and Metabolism
  • Oncology
  • Immunology and Allergy

Fingerprint Dive into the research topics of 'A randomized, placebo-controlled study on the effects of a nutraceutical combination of red yeast rice, Silybum marianum and octasonol on lipid profile, endothelial and inflammatory parameters'. Together they form a unique fingerprint.

Cite this